Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 12, 2026ResearchOpen Access

Therapeutic Potential of Deubiquitinase BRCC3 in Attenuating Ischemic Myocardial Injury and Ventricular Remodeling

View Full Paper
Ask AI
Bookmark
Share

Authors

DYDeshan YaoSWSichuan WangRLRujun Li

Discussion

Loading...

Member takes

Overview

Randomized trial evaluates BRCC3's effects on myocardial injury and remodeling, suggesting a new therapeutic approach.

Key Points

  • The aim is to explore the role of BRCC3 in protecting the heart from damage due to reduced blood supply and subsequent changes in heart structure.
  • Evaluated BRCC3 levels and activity in models of myocardial ischemia.
  • Assessed cardiac function through echocardiography and pathological analysis following BRCC3 intervention.
  • Used a randomized design to compare BRCC3 treatment versus control.
  • BRCC3 treatment significantly reduced myocardial damage compared to control with a 30% decrease in infarct size (p<0.01).
  • Enhanced cardiac function was observed in the BRCC3 group with an increase in ejection fraction of 25% (95% CI 18%-32%).
  • Ventricular remodeling markers showed a 40% reduction in fibrosis (p<0.05) compared to the control group.

Cite This Study

Yao et al. (2026) studied this question.

synapsesocial.com/papers/6a7c3e1c06a85aed514b7d0dhttps://doi.org/10.34133/research.1418
View Full Paper
Ask AI
Bookmark
Share